Information
"Create a virtuous cycle in clinical trials to provide more treatment opportunities for patients."
Founded in 2019 and headquartered in South Korea, MEDIAIPLUS provides innovative solutions to help pharmaceutical, biotech, and medical device companies conduct clinical trials more efficiently. To address bottlenecks in the clinical trial process, we have built the world’s largest clinical trial dataset and leverage AI to generate groundbreaking insights.
To achieve this, MEDIAIPLUS offers two key solutions. MediC is a subscription-based service that provides real-time access to a vast database of clinical trial reports, patents, regulations, and guidelines. FiCRO is an AI-driven solution that matches sponsors with the most suitable CROs for their specific clinical trials based on RFPs. MEDIAIPLUS’ AI-powered innovations in clinical trials have gained significant attention and recognition from key players in global clinical research.
Founded in 2019 and headquartered in South Korea, MEDIAIPLUS provides innovative solutions to help pharmaceutical, biotech, and medical device companies conduct clinical trials more efficiently. To address bottlenecks in the clinical trial process, we have built the world’s largest clinical trial dataset and leverage AI to generate groundbreaking insights.
To achieve this, MEDIAIPLUS offers two key solutions. MediC is a subscription-based service that provides real-time access to a vast database of clinical trial reports, patents, regulations, and guidelines. FiCRO is an AI-driven solution that matches sponsors with the most suitable CROs for their specific clinical trials based on RFPs. MEDIAIPLUS’ AI-powered innovations in clinical trials have gained significant attention and recognition from key players in global clinical research.